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Edited by Judit Ova´diAbstract A structural hallmark of lysosomes is heterogeneity
of their contents. We describe a method for isolation of parti-
culate materials from human placental lysosomes. After a
methionine methyl ester-induced disruption of lysosomes and
two density gradient centrifugations we obtained a homogeneous
membrane fraction and another one enriched in particulate inclu-
sions. The latter exhibited a yellow-brown coloration and con-
tained bodies lacking a delimiting membrane, which were
characterised by a granular pattern and high electron density.
The lipofuscin-like inclusion materials were rich in tripeptidyl
peptidase I, b-glucuronidase, acid ceramidase and apolipoprotein
D and contained proteins originating from diverse subcellular
localisations.
Here we show that human term placenta contains lipofuscin-
like lysosomal inclusions, a phenomenon usually associated with
senescence in postmitotic cells. These ﬁndings imply that a sim-
ple pelleting of a lysosomal lysate is not appropriate for the iso-
lation of lysosomal membranes, as the inclusions tend to be
sedimented with the membranes.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Lysosomes represent a degradative organelle of eukaryotic
cells. They are responsible for breakdown of macromolecules
known to be delivered to these organelles by endo-/phagocyto-
sis and autophagocytosis. Near complete degradation is
achieved by the action of more than 50 enzymes, mostly hydro-
lases [1]. Defects in these enzymes or in transporters releasing
the hydrolytic products into the cytosol result in lysosomal
storage. Under physiological conditions intralysosomally
stored materials are summarised under the term lipofuscin
and have been associated with ageing [2]. Characteristic fea-
tures of lipofuscin are yellow-brown coloration and autoﬂuo-
rescence with excitation wavelengths in the range from 320Abbreviations: 2D-PAGE, two-dimensional gel electrophoresis; CTAB,
N-cetyl-N,N,N-trimethylammonium bromide; MME, methionine
methyl ester; TPPI, tripeptidyl peptidase I
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pigments are frequently observed in senescent postmitotic cells
like neurons or cardiomyocytes and are considered to be unde-
gradable residues of incomplete intralysosomal breakdown [3].
Protein modiﬁcations by products of lipid peroxidation and
crosslinking of proteins are discussed as reasons for the resis-
tance towards proteinolytic degradation [4].
We disrupted lysosomes prepared from human placenta
using a hydrolysable substrate and isolated two particulate
fractions, the lysosomal membranes and aggregated lysosomal
inclusions, by two subsequent density gradient centrifugations.
The fraction containing the lipofuscin-like inclusions was
characterised by a proteomic analysis.2. Materials and methods
2.1. Subcellular fractionation
Fresh normal human term placentas were obtained from local
hospitals and transported on ice. Placental tissue was homogenised
and fractionated by a combination of diﬀerential centrifugation and
Percoll density gradient centrifugation as described previously [5].
A lysosome-enriched pool (‘‘dense pool’’) was collected from the bot-
tom third of the gradient. ‘‘Dense pool’’ (30 ml) was diluted ninefold
with isotonic Hepes buﬀer (250 mM sucrose, 10 mM Hepes-NaOH,
1 mM EDTA, pH 7.2) and centrifuged for 20 min at 11500 rpm
(15800 · gmax) in an SS-34 rotor (Sorvall, Bad Homburg, Germany).
The sediment was mixed with isotonic Hepes buﬀer and 100 mM
methionine methyl ester (MME) in this buﬀer to obtain 18 ml and a
ﬁnal concentration of 20 mM MME. The mixture was incubated for
30 min at room temperature to disrupt the lysosomes [6] and then ad-
justed to the following concentrations of proteinase inhibitors: 0.5 mM
iodoacetamide, 10 lM leupeptin, 1 mM phenylmethanesulfonyl
ﬂuoride and 1 lM Z-Phe-Phe-diazomethylketone and pepstatin A.
The sample was split and layered over two 28 ml sucrose gradients pre-
pared from solutions of 32.5% and 55% (w/v) sucrose in 10 mMHepes-
NaOH, 1 mM EDTA, pH 7.2. The gradients were centrifuged for 12 h
at 25000 rpm (112700 · gmax) in a SW-28 rotor (Beckman, Mu¨nchen,
Germany). Sixteen fractions, 2.3 ml each, were collected from the top.
The two fractions with the highest b-glucocerebrosidase activity were
combined (‘‘sucrose gradient pool’’) and further fractionated in a
self-forming iodixanol gradient. An isotonic iodixanol working solu-
tion was prepared according to manufacturer’s instructions containing
50% (w/v) iodixanol, 42 mM sucrose, 10 mM Hepes-NaOH, 1 mM
EDTA, pH 7.2, which was diluted with isotonic Hepes buﬀer to obtain
solutions with lower iodixanol concentrations. Per gradient 4.4 ml
‘‘sucrose gradient pool’’ were mixed with 5.4 ml 50% iodixanol work-
ing solution and 11.7 ml 10 mM Hepes-NaOH, 1 mM EDTA, pH 7.2,
and transferred into an Ultracrimp (Sorvall) polyallomer tube. A
cushion of 5 ml 40% (w/v) iodixanol solution was layered below and
6 ml of 12.5% (w/v) iodixanol solution and 2.5 ml isotonic Hepes buﬀer
above the sample. The gradients were centrifuged in a TV860 vertical
rotor (Sorvall) for 2 h at 50000 rpm (236500 · gmax) and divided intoblished by Elsevier B.V. All rights reserved.
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further analyses fractions 1–4 and 14–16 were pooled and will be re-
ferred to as ‘‘iodixanol upper and lower pools’’. From these pools
membranes and aggregated lysosomal inclusions were recovered by
dilution of the density gradient medium with 10 mM Tris–HCl, pH
7.4, and sedimentation in a 60Ti rotor (Beckman) for 2 h at
250000 · gmax followed by one step of washing in the same buﬀer
under the same conditions of centrifugation.2.2. Determination of enzyme activity and protein concentration
The activities of b-glucocerebrosidase [7] and succinate dehydroge-
nase [5] were determined at 37 C using spectrophotometric methods.
Tripeptidyl peptidase I (TPPI) activity was assayed in the presence
of 0.25 mM ﬂuorogenic substrate Ala-Ala-Phe-aminomethylcoumarin,
0.1% (w/v) Triton X-100, 0.1 M sodium acetate, pH 3.5, in a total
volume of 30 ll. Reaction was carried out for 20 min at 37 C and ter-
minated by the addition of 70 ll 0.4 M glycine–NaOH, pH 10.4. The
product, 7-amino-4-methylcoumarin, was quantiﬁed ﬂuorometrically
(kex ¼ 355 nm, kem ¼ 460 nm). Protein concentration was determined
by the method of Bradford [8]. Fluorescence of isolated intralysosomal
aggregates was examined in a SFM 25 spectralﬂuorometer (BioTek
instruments, Bad Friedrichshall, Germany). At several excitation
wavelengths ranging from 300 to 600 nm emission spectra were re-
corded in the range from kex to 700 nm.2.3. Polyacrylamide gel electrophoresis and Western blotting
Sample preparation and separation in SDS–PAGE was carried out
according to Laemmli [9]. Whereas aliquots (15 ll) of fractions from
sucrose gradient were subjected to SDS–PAGE directly, aliquots
(150 ll) of iodixanol gradient fractions were precipitated with trichlo-
roacetic acid (10% (w/v) ﬁnal concentration) prior to solubilisation.
Protein was visualised with silver nitrate [10]. For immunoblotting
electrophoretically separated proteins were transferred onto PVDF
membranes. Membranes were probed with anti-human LAMP-2
monoclonal antibody [11] or rabbit antibody raised against thiore-
doxin fusion protein of C-terminal fragment of human TPPI (from
Dr. E. Kominami, Juntendo University, Tokyo) and HRP-coupled
secondary antibodies (Bio-Rad, Munich, Germany) that were
visualised using ECL Plus Kit (GE Healthcare Life Sciences, Freiburg
i. Br., Germany).2.4. Electron microscopy
For electron microscopy pooled fractions from the gradient were
mixed with the same volume of a ﬁxation solution [12] containing
2.5% glutaraldehyde, 2.5% paraformaldehyde, 0.05% (w/v) picric acid
in 0.1 M cacodylate buﬀer (pH 7.35). Samples were incubated on ice
for 1 h and subsequently sedimented at 90600 · gmax for 1 h. The pel-
lets were washed three times in 0.1 M cacodylate buﬀer and postﬁxed
in 2% OsO4 for 1 h. Standard procedures for dehydration and embed-
ding in Epon were employed. Thin sections were stained with uranyl
acetate and lead citrate and examined with a Zeiss EM109 electron
microscope.Fig. 1. Workﬂow for puriﬁcation of lysosomal membranes and
inclusions.2.5. Diagonal two-dimensional PAGE and mass spectrometric
identiﬁcation of spots
Electrophoretic separation of proteins combining a N-cetyl-N,N,N-
trimethylammonium bromide (CTAB)–PAGE in the ﬁrst with an
SDS–PAGE in the second dimension was performed as described pre-
viously [13]. The samples were preincubated in the presence of 50 mM
Tris–HCl, pH 8.5, 1% (w/v) CTAB, 30 mM DTT for 10 min at 60 C.
Then 2 volumes of 4.5 M urea, 1% (w/v) CTAB, 96 mM KOH,
141 mM acetic acid, pH 5.1, 7.5% (v/v) glycerol were added and the
samples were heated for 5 min at 60 C. Protein was stained with
colloidal Coomassie brilliant blue according to Neuhoﬀ et al. [14].
To identify proteins, gel plugs (2 mm diameter) were excised and sub-
jected to tryptic in gel digestion according to standard protocols. Pep-
tides were applied manually to a MALDI sample support precoated
with a-cyano-4-hydroxycinnamic acid and mass spectra acquired with
an Ultraﬂex I MALDI-TOF/TOF mass spectrometer (Bruker Dalton-
ics, Bremen, Germany) in an automated mode as described by Jahn
et al. [15]. For each sample a peptide mass ﬁngerprint and four
MS/MS spectra were recorded that were used for a combined database
search with BioTools 3.0 software (Bruker Daltonics) and the Mascotsearch engine in NCBI and SwissProt protein databases. Protein
hits with Mascot scores higher than 75 were considered to be signiﬁ-
cant.3. Results
3.1. Fractionation of placental lysosomes
The fractionation workﬂow is shown in Fig. 1. The ‘‘dense
pool’’ recovered from the Percoll gradient was enriched 45-
fold in b-hexosaminidase and 7.5-fold in succinate dehydroge-
nase activity (n ¼ 8) as compared to the homogenate. Electron
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and mitochondria to be the major constituents (Fig. 4A). The
contents of lysosomes varied from homogeneously electron
dense lysosomal matrices with a dotted and ﬁnely granulated
pattern to amorphous clumps of high electron density and
transparent vacuolar inclusions.
After incubating the ‘‘dense pool’’ lysosomes with
methionine methyl ester the disrupted membranes were sepa-
rated from mitochondria in a sucrose gradient. In a represen-
tative gradient shown in Fig. 2 the sublysosomal membrane
vesicles characterised by the presence of b-glucocerebrosidase
activity (Fig. 2A) and LAMP-2 protein (Fig. 2B) were enriched
in fraction 5 (mean density 1.15 g/cm3). The mitochondria
(succinate dehydrogenase activity) band at a higher density
with a maximum in fraction 9. If the substrate-induced lyso-
somal disruption was omitted, the distributions of lysosomes
and mitochondria overlapped resulting in poor separation of
these two organelles (not shown). The activity of the soluble
lysosomal matrix enzyme b-hexosaminidase peaked in fraction
3 (not shown) indicating that after MME-induced disruption
lysosomal membranes and soluble contents could be separated
from each other.
Fractions 5 and 6, containing the bulk of lysosomal mem-
branes with little mitochondrial contamination, were pooled
(‘‘sucrose gradient pool’’) and further fractionated using an
iodixanol density gradient. As shown for a representative
separation (Fig. 3) a sigmoidal density proﬁle with a shallow
middle region was obtained (Fig. 3A). The majority of sublyso-
somal membrane vesicles was ﬂoating into the top fractionsFig. 2. Separation of ‘‘dense pool’’ in a sucrose gradient after
substrate-induced lysis. (A) The activities of b-glucocerebrosidase
(b-Gluc, m), succinate dehydrogenase (Succ DH, s) and TPPI (j)
were determined in fractions of a representative gradient. TPPI activity
was expressed as percentage of the total activity of all gradient
fractions. (B) Aliquots of the fractions were separated in SDS–PAGE.
Proteins were transferred to a PVDF membrane and probed with
antibodies as indicated in the ﬁgure.
Fig. 3. Fractionation of ‘‘sucrose gradient pool’’ in a self-forming
iodixanol gradient. (A) Fractions of an iodixanol gradient were
assayed for activities of b-glucocerebrosidase (b-Gluc, m) and TPPI
(j) and protein concentration ($). One arbitrary unit corresponds to a
b-glucocerebrosidase activity of 1 mU/ml, a TPPI activity of 7.5% of
the total activity in all gradient fractions and a protein concentration
of 10 lg/ml. The refractive index (—) in the fractions demonstrates the
sigmoidal proﬁle of the density gradient. In (B) and (C) protein from
aliquots of gradient fractions was subjected to SDS–PAGE. LAMP-2
and TPPI (C) were detected by Western blotting and protein by
staining with silver nitrate (B). The open and closed arrowheads
indicate the positions of LAMP-2 and TPPI.1–4 (‘‘iodixanol upper pool’’) and separated from the bulk of
protein that was recovered in fractions 14–16 (‘‘iodixanol
lower pool’’) and reproducibly associated with a conspicuous
yellow band. SDS–PAGE analysis of the gradient fractions re-
vealed major diﬀerences in protein composition and band pat-
tern between the two pools (Fig. 3B). The open and
closed arrowheads indicate the positions of LAMP-2 and
TPPI, respectively, as examples of proteins being enriched
in fractions of ‘‘iodixanol upper’’ and ‘‘lower pool’’. The
pooled materials were examined by electron microscopy. The
Fig. 4. Electron microscopic examination of diﬀerent pools. The
‘‘dense’’ (A), ‘‘iodixanol upper’’ (B) and ‘‘iodixanol lower pools’’ (C)
were ﬁxed and processed for electron microscopy as described.
Magniﬁcation: 40000·; Arrows: a membrane sheet adhering to a
granulated body; Bar = 200 nm.
Fig. 5. Preparative diagonal 2D-PAGE of lysosomal inclusion bodies.
The sediment of ‘‘iodixanol lower pool’’ after ultracentrifugation and
washing (180 lg protein) was subjected to a diagonal 2D-PAGE.
Protein was visualised by staining with colloidal Coomassie brilliant
blue. Numbers refer to proteins listed in Table 1. In the second
dimension the sample proteins migrated with a lag as compared to the
molecular weight marker. The spots Nos. 161 and 164 with an
abnormal rapid migration in the second dimension were not observed
in similar separations and are considered an artefact.
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homogeneous preparation of sublysosomal membrane vesicles.
The morphological examination of ‘‘iodixanol lower pool’’
(Fig. 4C) revealed the presence of electron-dense bodies. These
were heterogeneous in shape and their granular ultrastructure
resembled that of the lysosomal contents seen in ‘‘dense pool’’
lysosomes (Fig. 4A). The majority of these bodies was free of a
delimiting membrane. Residual membrane sheets adhering to
these bodies were seen sporadically (Fig. 4C, arrows). The pres-
ence of membrane vesicles in the lower pool in addition to the
aggregates was consistent with the detection of b-glucocerebro-
sidase (Fig. 3A) and LAMP-2 (Fig. 3C) in these fractions. The
particulate material of presumably intralysosomal origin obvi-
ously co-localised with the lysosomal membranes in the sucrose
gradient pool. Then, under the isoosmotic conditions of the
iodixanol gradient, the properties of both species were suﬃ-
ciently diﬀerent to allow separation (mean densities of ‘‘iodix-
anol upper and lower pools’’: 1.06 g/cm3 and 1.12 g/cm3).3.2. Characterisation of the lysosomal inclusions
The sedimentable materials from ‘‘iodixanol lower pool’’
were separated in a diagonal 2D-PAGE using strong ionic
detergents in both dimensions (Fig. 5). Altogether 34 diﬀerent
proteins were identiﬁed as listed in Table 1. Among these,
seven are marked in italics referring to their prominent pres-
ence in the ‘‘iodixanol upper pool’’ (not shown). Therefore
they are considered to originate from lysosomal membranes
rather than from the inclusion bodies. LAMP-1 and -2,
although equally abundant in the lysosomal membrane as
LIMP-2, were not identiﬁed. Due to size and modiﬁcations
the number of tryptic peptides detectable by MALDI-TOF-
MS is much lower for these proteins than for LIMP-2 making
unequivocal identiﬁcation of small amounts of LAMP-1 and
-2 diﬃcult with the proteomic technology used. The remaining
27 proteins on the list are likely constituents of the inclusions.
Ten of them originate from mitochondria, four from the ER,
three from cytosol, two are plasma proteins and four are
primarily associated with granules in phagocytic leukocytes.
Despite some variations in spot pattern between preparations
from diﬀerent placentas the major constituents of this material
were three lysosomal matrix proteins: TPPI, b-glucuronidase
and acid ceramidase. Another reproducibly abundant protein
was apolipoprotein D. Although stringent conditions for dena-
turing and solubilising the proteins had been applied, the 2D
pattern revealed a number of diﬀusely stained areas lacking
clear delineation in addition to the major spots. The main
spot of TPPI (spot-No. 83) migrated as expected for the
mature enzyme which has a molecular weight of 46 kDa [16].
Table 1
Proteins identiﬁed in lysosomal inclusion bodies
Protein Acc.-No.a MWb (kDa) Spot No.c
Acid ceramidase Q13510 44.7 43, 104
Actin, beta P60709 41.7 71
ADP/ATP translocase 2 (SLC25A5) P05141 32.8 126
ADP/ATP translocase 3 (SLC25A6) P12236 32.7 126
ADP-ribosylation factor-like 10 C Q9NVJ2 21.5 154
Alkaline phosphatase P05187 58.0 32
Alpha-2-macroglobulin P01023 163.3 16, 19, 85
Apolipoprotein D P05090 21.3 145
ATP synthase alpha chain, mitochondrial P25705 59.7 135
ATP synthase beta chain, mitochondrial P06576 56.6 66
Azurocidin (CAP 37) P20160 26.9 121, 128, 129
Beta-galactosidase P16278 76.1 41
Beta-glucocerebrosidase P04062 59.7 34
Beta-glucuronidase P08236 74.7 2, 6, 9, 14, 164
Calpain-6 (calpamodulin) Q9Y6Q1 74.6 28
Cathepsin G P08311 28.8 137, 161
Creatine kinase, mitochondrial P12532 47.0 77
Cytochrome P450 11A1, mitochondrial P05108 60.2 69
Cytochrome P450 19A1 P11511 57.8 135
Dihydrolipoamide succinyltransferase component of 2-oxoglutarate dehydrogenase P36957 48.6 124
Dolichyl-diphosphooligosasaccharide-protein-glycosylransferase 48 kDa subunit P39656 48.8 67
Glucose-regulated protein, 78 kDa P11021 72.3 23
Glyceraldehyde-3-phosphate dehydrogenase P04406 35.9 90
Heat shock protein 60 kDa (HSP60) P10809 61.1 45
LIMP-2 Q14108 54.2 25
Monoamine oxidase type A P21397 59.7 30, 34, 40, 100
Myeloblastin (leukocyte proteinase 3) P24158 27.8 121, 124, 129, 131
Myeloperoxidase P05164 83.9 49
Steryl-sulfatase P08842 65.5 37
Tripeptidyl peptidase I O14773 61.2 83, 141, 149, 152, 158
V0-ATPase d P61421 40.3 63
V1-ATPase A P38606 68.3 25
V1-ATPase B P21281 56.5 56, 58
VDAC 1 (porin 31 HL/HM) P21796 30.6 92
Proteins printed in italics are of higher abundance in ‘‘iodixanol upper pool’’ and likely constituents of the lysosomal membranes.
aDatabase accession numbers refer to Swiss Prot database http://www.expasy.org.
bMolecular mass values refer to those in the database.
cSpot numbers refer to the positions shown in Fig. 4.
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possibly indicating proteinolytic breakdown.
3.3. Tripeptidyl peptidase I in the course of lysosomal
fractionation
In both gradients the proﬁle of the enzyme activity
(Figs. 2A, 3A) correlated well with the signals from immune
detection (Figs. 2B, 3C). In the sucrose gradient TPPI was
distributed similar to LAMP-2. However, in the iodixanol
gradient the bulk of TPPI was separated from the membrane
marker and recovered in the ‘‘iodixanol lower pool’’ contain-
ing the lysosomal inclusions. The maximum of TPPI (fraction
15) was diﬀerent from that of lysosomal membrane markers
(fraction 14) also being present in this part of the gradient.4. Discussion
Upon disruption of placental lysosomes, particulate lipofus-
cin-like materials were released that could be separated from
membranes. These materials were not autoﬂuorescent but
exhibited a yellow-brown coloration. There have been
contradictory reports about the existence of lipofuscin in
human placenta based solely on the microscopic detection
of autoﬂuorescent pigments [17,18]. Rather surprisingly,placenta, an organ continuously growing in the course of a
pregnancy, contains signiﬁcant amounts of lipofuscin-like
lysosomal inclusions as shown in this study what is usually
considered as a hallmark of ageing.
Two studies have analysed the proteome of lipofuscin iso-
lated from retina pigment epithelium. Schutt et al. were able
to identify 60 proteins by mass spectrometry after separation
in conventional 2D-PAGE [19]. Warburton et al. detected 41
proteins taking a combined approach with 1D-SDS and 2D-
PAGE [20]. Only six of the 27 proteins that were detected in
intralysosomal aggregates in the present study (actin, a- and
b-chains of mitochondrial ATP synthase, glucose-regulated
protein, glyceraldehyde-3-phosphate dehydrogenase and porin
VDAC 1) have also been reported by Schutt et al. [19,20].
Merely three of the proteins (actin, b-chain of mitochondrial
ATP synthase, TPPI) overlap with the list by Warburton
et al. [20]. A common ﬁnding is that proteins originating from
varied subcellular locations are detected. The diﬀerences be-
tween the results may reﬂect the dissimilarities regarding the
tissue examined.
The diagonal 2D-PAGE separation shown in Fig. 5 demon-
strated proteins with apparent molecular weights between
20 kDa and 110 kDa. High molecular weight proteins were
obviously underrepresented in the inclusion bodies. Proteins
below 20 kDa were not reliably separated. Subunit c of the
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major constituents of the storage material in several types of
neuronal ceroid lipofuscinoses [21] would not have been
resolved if they had been present in the lysosomal inclusion
bodies. The apparently smeary separation of the stained
protein (Fig. 5) might indicate that the lysosomal inclusions
are heterogeneous mixtures of modiﬁed proteins unlikely to
be separated into discrete spots and identiﬁed in completeness.
Those identiﬁed may represent the most prominent com-
ponents of an undegradable residue and lysosomal matrix
proteins that tend to associate with this residue.
It seems likely that autophagocytosed organelles represent
the origin of the reported intralysosomal aggregates. Auto-
phagocytosis has been observed in human syncytiotrophoblast
[22] and lysosomes have been postulated to play a role in mem-
brane turnover during diﬀerentiation of cytotrophoblast to
syncytiotrophoblast [23]. Furthermore trophoblastic cells have
been shown to perform phagocytosis [24,25] which may be
important for their invasion into the maternal endometrium
and the extensive tissue remodelling that is characteristic of
early placenta development [25,26]. Thus, the observed intra-
lysosomal aggregates may also represent residues from cells
and materials internalised by phagocytosis during this phase.
TPPI has been reported to behave like a soluble lysosomal
enzyme in brain extracts [27]. The enzyme has been puriﬁed
to homogeneity from diﬀerent species and tissues and shown
to aggregate and oligomerise under acidic conditions [28–30].
Defects in TPPI cause the late infantile type of neuronal ceroid
lipofuscinosis (NCL) [31]. The enzyme has been demonstrated
to interact with the CLN5 protein, reportedly an integral mem-
brane protein [32]. This may implicate an association of TPPI
with the lysosomal membrane which, however, was not de-
tected in this study. It has been reported that the TPPI content
of human brain tissue increases with age [33]. This ﬁnding may
be explained by an accumulation of lipofuscin-like storage
materials binding TPPI.
According to current protocols lysosomal membranes are
isolated by sedimenting disrupted lysosomes prepared by
freeze-thawing or sonication. By this means soluble lysosomal
matrix enzymes are removed but particulate lysosomal inclu-
sions are enriched along with the membranes. Fractionation
of membranes and intralysosomal aggregates can be achieved
by combining a speciﬁc substrate-induced lysis of lysosomes
followed by a separation using density gradients. This
methodology should facilitate studies on lysosomal inclusions
from other sources and tissues.
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